Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00697_DB00726_nanopub.RAYNUc-DFpVZ1BB9X-nxRfhg7TCD0CHifsbu822etUjdU#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00697_DB00726 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00697_DB00726 label "DDI between Tizanidine and Trimipramine - Trimipramine may reduce the antihypertensive effect of the alpha2-agonist, Tizandine. Trimipramine may also increase the rebound hypertensive effect of Clonidine. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Clonidine if Trimipramine is initiated, discontinued or dose changed. Tizandine should be withdrawn very gradually to reduce the risk of hypertensive crisis. [drugbank_resource:DB00697_DB00726]" assertion.
- drugbank_resource:DB00697_DB00726 identifier "drugbank_resource:DB00697_DB00726" assertion.
- drugbank_resource:DB00697_DB00726 title "DDI between Tizanidine and Trimipramine - Trimipramine may reduce the antihypertensive effect of the alpha2-agonist, Tizandine. Trimipramine may also increase the rebound hypertensive effect of Clonidine. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Clonidine if Trimipramine is initiated, discontinued or dose changed. Tizandine should be withdrawn very gradually to reduce the risk of hypertensive crisis." assertion.
- drugbank:DB00697 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00697_DB00726 assertion.
- drugbank:DB00726 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00697_DB00726 assertion.